Background. IMP CPE are the dominant CPE type in Japan. We aimed to compare its epidemiology to that of non-CPE (NCPE).
Methods. Patients with isolation of carbapenem-resistant Enterobacteriaceae (CRE) with meropenem MIC ≥2 mg/L or imipenem MIC ≥2 mg/L and cefmetazole MIC ≥64 mg/L were included from August 2016 to March 2018. Adjusted outcome analyses were conducted using a generalized estimating equation model with weighting based on the inverse probability of propensity scores (PS).
Results. Ninety isolates (27 CPE and 63 NCPE) were collected from 88 patients (53 male) in 7 hospitals. CPE included 10 E. cloacae (ENC), 6 K. pneumoniae (KP), 4 E. coli (EC), 3 C. freundii (CF), 2 K. oxytoca, and 1 each of E. aerogenes (EA) and S. marcescens (SM). NCPE included 34 EA, 15 ENC, 4 each of KP, SM, and 2 CF. All CPE were positive for IMP carbapenemase (4) (5) (6) , and 3 each of IMP-10 and IMP-1). Most of CPE/NCPE were isolated from sputum (39%), intra-abdomen (21%), and urine (20%). Levofloxacin, gentamicin, and amikacin resistance were found in 6 (22%), 4 (15%), and 1 (4%) CPE, respectively, and 6 (10%), 6 (10%), and 0 NCPE, respectively. Eighteen (67%) bla IMP were transferable by conjugation. Cases of CPE involved older patients with more frequent use of devices and carbapenem exposure than those in cases of NCPE (table) . The mortality was similar in the 2 groups. Length of hospital stay (LOS) after CPE/NCPE isolation was significantly higher in the CPE group after PS adjustment (P = 0.02). Conclusion. CPE had distinct epidemiological characteristics, and CPE isolation was associated with a prolonged hospital stay. Defining the underlying resistance mechanism of CRE is important for appropriate management.
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Epidemiology of End-stage Renal Disease (ESRD) Patients with Carbapenem-Resistant Enterobacteriaceae (CRE) Infections: Atlanta Metropolitan
Area, 2012-2017 Jacqueline M. Hurd, MPH, RN 1 ; Chris W. Bower, MPH 2 and Jesse T. Jacob, MD, MSc 3 ; 1 GAEIP, Atlanta, Georgia; 2 Georgia Emerging Infections Program, Decatur, Georgia; 3 Emory University, Atlanta, Georgia Session: 54. HAI: MDRO -GNR Epidemiology, CRE Thursday, October 3, 2019: 12:15 PM Background. Patients with end-stage renal disease (ESRD) have higher risks for resistant organisms including carbapenem-resistant Enterobacteriaceae (CRE). To explore the effect of ESRD on CRE, we compared characteristics of CRE cases with and without ESRD in a population-based cohort.
Methods. The Georgia Emerging Infections Program has performed active laboratory-and population-based surveillance for CRE in metropolitan Atlanta (4.1 million in 2017) since 2012. CRE cases are defined by isolation from a sterile body site or urine of E. coli, K. pneumoniae, K. oxytoca, K. aerogenes, or E. cloacae. From 2012 to 2015, cultures were resistant to all third-generation cephalosporins tested and non-susceptible to ≥1 carbapenem (excluding ertapenem). After 2016, cultures were resistant to ≥1 carbapenems. Epidemiologic data including ESRD were collected via medical chart review. ESRD population data were obtained from the US Renal Data System. Georgia vital records data were used to determine 90-day mortality rates. Prevalence estimates were calculated. Comparisons used a χ 2 test.
Results. Of 1,511 CRE cases, 136 (9%) were on current chronic dialysis, 128 (94%) of which were on hemodialysis (HD) and 5 (4%) were on peritoneal dialysis. Among CRE cases with HD, 94 (73%) had a catheter and 30 (23%) had an arteriovenous fistula or graft. CRE cases with ESRD were more likely to be male (58% vs. 40%), black (76% vs. 38%), and have diabetes (67% vs. 38%), congestive heart failure (25% vs. 17%), or peripheral arterial disease (12% vs. 4%). CRE cases with ESRD had more hospitalizations within 30 days of the culture date (77% vs. 47%), ICU admissions prior to (29% vs. 7%) or after the culture date (43% vs. 14%) and discharges to LTCFs (35% vs. 15%) after hospitalization. CRE cases with ESRD and bacteremia were more likely to have been hospitalized >3 days before the culture compared with CRE cases with ESRD and positive cultures from other body sites (52% vs. 24%). The 90-day mortality rate per 100,000 population was higher among CRE cases with ESRD (100.9 cases) than without ESRD (1.0 cases).
Conclusion. Among a population-based cohort of patients with CRE infections, ESRD comprised ~10% but had markedly mortality, suggesting that future interventions should target ESRD.
Disclosures. All authors: No reported disclosures. Methods. Klebsiella pneumoniae carbapenemase producing-K. quasipneumoniae (KPC-Kq) isolates from patients and wastewater sites from drains and toilets were sequenced (Illumina). Sequence assemblies (SPAdes) were probed in silico for AMR genes and plasmid Incompatibility types (using AMRFinder and PlasmidFinder databases, respectively). For related isolates (<100 SNV) cultured from the same sites longitudinally, we compared the accumulation of AMR genes in patients and environmental reservoirs over time.
Making of a "Super-Duper
Results. From 2009 to 2016 there were a total of 15 KPC-Kq isolates from 8 patients and 17 environmental isolates from 11 rooms. The mean number of resistance genes identified in patients and environmental isolates were 15 and 14, respectively (P = NS), with five resistance genes carried by all isolates including bla KPC . There was an average of 4.4 unique incompatibility types from patients and 4.0 from the environment (P = NS). For the longitudinal subset, there were 17 related isolates from two patients and two sink drains. One hospitalized patient with repeated antimicrobial exposure had a KPC-Kq initial isolate with 3 plasmid types and 13 AMR genes and died one year later with a KPC-Kq isolated from blood with 11 plasmid types and 25 AMR genes. The other patient was primarily an outpatient with little antimicrobial exposure. His KPC-Kq lost 1 plasmid and 3 AMR genes over 15 months. One KPC-Kq strain in the environment lost 3 plasmid types and 8 AMR genes over 4 months; the other was unchanged over 5 months.
Conclusion. KPC-Kq has been seen in both patients and the environment for several years at our institution. Sequencing of longitudinal isolates revealed that under antimicrobial pressure a patient KPC-Kq accumulated multiple plasmids and AMR genes. This same accumulation was not witnessed environmental sites over time although the numbers are small and will require confirmatory work.
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Urinary Catheters Are Associated with Progression from Bacteriuria to Invasive Infections in Patients with

Background.
Patients with carbapenem-resistant Enterobacteriaceae (CRE) bacteriuria have better outcomes than patients with an invasive CRE infection, but patients with bacteriuria may subsequently develop an invasive infection ("progression"). We sought to evaluate risk factors, particularly urinary catheters, for progression from CRE bacteriuria to an invasive CRE infection within one year.
Methods. We used population-based active surveillance data from the Georgia Emerging Infections Program to identify patients in metropolitan Atlanta with CRE in urine, but not in a concomitant or previous sterile site between August 1, 2011 and July 31, 2017. CRE was defined as an isolate resistant to tested third-generation cephalosporins and a minimum inhibitory concentration of ≥4 µg/mL for meropenem, doripenem or imipenem. We then assessed if these patients developed an invasive CRE infection (positive sterile site culture) with the same organism between one day and one year later. Demographics, culture site, comorbidities, and risk factors were obtained by chart review. Univariable analyses and multivariable logistic regression with progression as the outcome were performed in SAS 9.4.
Results. We identified 551 patients with CRE bacteriuria in 6 years, with an annual incidence of 1.1 cases/100,000 population. Many patients previously resided in long-term care facilities (48%), had a Charlson comorbidity index (CCI) >3 (38%), a central venous catheter (CVC, 34%) or a decubitus ulcer (27%, Table 1 ). Twenty-five patients (5%) progressed from CRE bacteriuria to an invasive CRE infection within one year (median 34 days). Predictors of progression in univariable analyses included the presence of a urinary catheter (OR 6.4 [95% CI: 1.9-21.6]), decubitus ulcer, CVC or other indwelling device, Klebsiella pneumoniae, black race, CCI >3, and ICU stay after urine culture was obtained (Table 2 ). In a multivariable analysis, urinary catheter (OR 4.6 [95% CI: 1.3-16.1]) predicted progression as well as K. pneumoniae, CCI >3 and CVC.
Conclusion. Progression from CRE bacteriuria to an invasive CRE infection is rare but clinically significant and is associated with urinary catheters. Future interventions should target urinary catheter removal, where possible, in patients with CRE bacteriuria.
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